319 results on '"Dong, Tien S."'
Search Results
2. Validation of a Machine Learning Algorithm, EVendo, for Predicting Esophageal Varices in Hepatocellular Carcinoma
- Author
-
Yang, Jamie O., Chittajallu, Punya, Benhammou, Jihane N., Patel, Arpan, Pisegna, Joseph R., Tabibian, James, and Dong, Tien S.
- Published
- 2024
- Full Text
- View/download PDF
3. The Association Between a Mediterranean Diet and Symptoms of Irritable Bowel Syndrome
- Author
-
Chen, Ellie Y, Mahurkar-Joshi, Swapna, Liu, Cathy, Jaffe, Nancee, Labus, Jennifer S, Dong, Tien S, Gupta, Arpana, Patel, Shravya, Mayer, Emeran A, and Chang, Lin
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Genetics ,Nutrition ,Digestive Diseases ,Chronic Pain ,Pain Research ,Oral and gastrointestinal ,Humans ,Irritable Bowel Syndrome ,Diet ,Mediterranean ,Gastrointestinal Diseases ,Food ,Gastrointestinal Microbiome ,Diet ,Mediterranean Diet ,Symptoms ,Microbiome. ,Microbiome ,Clinical Sciences ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
Background & aimsLow adherence to Mediterranean diet (MD) has been shown to be associated with a higher prevalence of irritable bowel syndrome (IBS), but its association with IBS symptoms is not established. We aim to assess the association between MD and IBS symptoms, identify components of MD associated with IBS symptoms, and determine if a symptom-modified MD is associated with changes in the gut microbiome.MethodsOne hundred and six Rome +IBS and 108 health control participants completed diet history and gastrointestinal symptom questionnaires. Adherence to MD was measured using Alternate Mediterranean Diet and Mediterranean Diet Adherence Screener. Sparse partial least squares analysis identified MD food items associated with IBS symptoms. Stool samples were collected for 16S ribosomal RNA gene sequencing and microbial composition analysis in IBS subjects.ResultsAlternate Mediterranean Diet and Mediterranean Diet Adherence Screener scores were similar between IBS and health control subjects and did not correlate with Irritable Bowel Syndrome Severity Scoring System, abdominal pain, or bloating. Among IBS participants, a higher consumption of fruits, vegetables, sugar, and butter was associated with a greater severity of IBS symptoms. Multivariate analysis identified several MD foods to be associated with increased IBS symptoms. A higher adherence to symptom-modified MD was associated with a lower abundance of potentially harmful Faecalitalea, Streptococcus, and Intestinibacter, and higher abundance of potentially beneficial Holdemanella from the Firmicutes phylum.ConclusionsA standard MD was not associated with IBS symptom severity, although certain MD foods were associated with increased IBS symptoms. Our study suggests that standard MD may not be suitable for all patients with IBS and likely needs to be personalized in those with increased symptoms.
- Published
- 2024
4. Microbial changes from bariatric surgery alters glucose-dependent insulinotropic polypeptide and prevents fatty liver disease
- Author
-
Dong, Tien S, Katzka, William, Yang, Julianne C, Chang, Candace, Arias-Jayo, Nerea, Lagishetty, Venu, Balioukova, Anna, Chen, Yijun, Dutson, Erik, Li, Zhaoping, Mayer, Emeran A, Pisegna, Joseph R, Sanmiguel, Claudia, and Jacobs, Jonathan P
- Subjects
Microbiology ,Biological Sciences ,Prevention ,Digestive Diseases ,Obesity ,Nutrition ,Chronic Liver Disease and Cirrhosis ,Liver Disease ,Oral and gastrointestinal ,Animals ,Mice ,Non-alcoholic Fatty Liver Disease ,Obesity ,Morbid ,Gastrointestinal Microbiome ,Bariatric Surgery ,Receptors ,G-Protein-Coupled ,Peptides ,Glucose ,Akkermansia ,GIP ,NAFLD ,bariatric surgery ,sleeve gastrectomy - Abstract
Bariatric surgery remains a potent therapy for nonalcoholic fatty liver disease (NAFLD), but its inherent risk and eligibility requirement limit its adoption. Therefore, understanding how bariatric surgery improves NAFLD is paramount to developing novel therapeutics. Here, we show that the microbiome changes induced by sleeve gastrectomy (SG) reduce glucose-dependent insulinotropic polypeptide (GIP) signaling and confer resistance against diet-induced obesity (DIO) and NAFLD. We examined a cohort of NALFD patients undergoing SG and evaluated their microbiome, serum metabolites, and GI hormones. We observed significant changes in Bacteroides, lipid-related metabolites, and reduction in GIP. To examine if the changes in the microbiome were causally related to NAFLD, we performed fecal microbial transplants in antibiotic-treated mice from patients before and after their surgery who had significant weight loss and improvement of their NAFLD. Mice transplanted with the microbiome of patients after bariatric surgery were more resistant to DIO and NAFLD development compared to mice transplanted with the microbiome of patients before surgery. This resistance to DIO and NAFLD was also associated with a reduction in GIP levels in mice with post-bariatric microbiome. We further show that the reduction in GIP was related to higher levels of Akkermansia and differing levels of indolepropionate, bacteria-derived tryptophan-related metabolite. Overall, this is one of the few studies showing that GIP signaling is altered by the gut microbiome, and it supports that the positive effect of bariatric surgery on NAFLD is in part due to microbiome changes.
- Published
- 2023
5. Predictive Algorithm for Hepatic Steatosis Detection Using Elastography Data in the Veterans Affairs Electronic Health Records
- Author
-
Bangaru, Saroja, Sundaresh, Ram, Lee, Anna, Prause, Nicole, Hao, Frank, Dong, Tien S, Tincopa, Monica, Cholankeril, George, Rich, Nicole E, Kawamoto, Jenna, Bhattacharya, Debika, Han, Steven B, Patel, Arpan A, Shaheen, Magda, and Benhammou, Jihane N
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Digestive Diseases ,Liver Disease ,Chronic Liver Disease and Cirrhosis ,4.1 Discovery and preclinical testing of markers and technologies ,Oral and gastrointestinal ,Good Health and Well Being ,Humans ,Non-alcoholic Fatty Liver Disease ,Elasticity Imaging Techniques ,Liver ,Veterans ,Electronic Health Records ,Prospective Studies ,ROC Curve ,Liver Diseases ,Alcoholic ,Biopsy ,Liver Cirrhosis ,Nonalcoholic fatty liver disease ,Prediction ,Model ,Elastography ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
Background and aimsNonalcoholic fatty liver disease (NAFLD) has reached pandemic proportions. Early detection can identify at-risk patients who can be linked to hepatology care. The vibration-controlled transient elastography (VCTE) controlled attenuation parameter (CAP) is biopsy validated to diagnose hepatic steatosis (HS). We aimed to develop a novel clinical predictive algorithm for HS using the CAP score at a Veterans' Affairs hospital.MethodsWe identified 403 patients in the Greater Los Angeles VA Healthcare System with valid VCTEs during 1/2018-6/2020. Patients with alcohol-associated liver disease, genotype 3 hepatitis C, any malignancies, or liver transplantation were excluded. Linear regression was used to identify predictors of NAFLD. To identify a CAP threshold for HS detection, receiver operating characteristic analysis was applied using liver biopsy, MRI, and ultrasound as the gold standards.ResultsThe cohort was racially/ethnically diverse (26% Black/African American; 20% Hispanic). Significant positive predictors of elevated CAP score included diabetes, cholesterol, triglycerides, BMI, and self-identifying as Hispanic. Our predictions of CAP scores using this model strongly correlated (r = 0.61, p
- Published
- 2023
6. Discrimination exposure impacts unhealthy processing of food cues: crosstalk between the brain and gut
- Author
-
Zhang, Xiaobei, Wang, Hao, Kilpatrick, Lisa A, Dong, Tien S, Gee, Gilbert C, Labus, Jennifer S, Osadchiy, Vadim, Beltran-Sanchez, Hiram, Wang, May C, Vaughan, Allison, and Gupta, Arpana
- Subjects
Biological Psychology ,Biomedical and Clinical Sciences ,Psychology ,Nutrition ,Digestive Diseases ,Prevention ,Neurosciences ,Behavioral and Social Science ,Basic Behavioral and Social Science ,Obesity ,Stroke ,Mental health ,Oral and gastrointestinal - Abstract
Experiences of discrimination are associated with adverse health outcomes, including obesity. However, the mechanisms by which discrimination leads to obesity remain unclear. Utilizing multi-omics analyses of neuroimaging and fecal metabolites, we investigated the impact of discrimination exposure on brain reactivity to food images and associated dysregulations in the brain-gut-microbiome system. We show that discrimination is associated with increased food-cue reactivity in frontal-striatal regions involved in reward, motivation and executive control; altered glutamate-pathway metabolites involved in oxidative stress and inflammation as well as preference for unhealthy foods. Associations between discrimination-related brain and gut signatures were skewed towards unhealthy sweet foods after adjusting for age, diet, body mass index, race and socioeconomic status. Discrimination, as a stressor, may contribute to enhanced food-cue reactivity and brain-gut-microbiome disruptions that can promote unhealthy eating behaviors, leading to increased risk for obesity. Treatments that normalize these alterations may benefit individuals who experience discrimination-related stress.
- Published
- 2023
7. How Discrimination Gets Under the Skin: Biological Determinants of Discrimination Associated With Dysregulation of the Brain-Gut Microbiome System and Psychological Symptoms
- Author
-
Dong, Tien S, Gee, Gilbert C, Beltran-Sanchez, Hiram, Wang, May, Osadchiy, Vadim, Kilpatrick, Lisa A, Chen, Zixi, Subramanyam, Vishvak, Zhang, Yurui, Guo, Yinming, Labus, Jennifer S, Naliboff, Bruce, Cole, Steve, Zhang, Xiaobei, Mayer, Emeran A, and Gupta, Arpana
- Subjects
Biological Psychology ,Biomedical and Clinical Sciences ,Psychology ,Nutrition ,Clinical Research ,Basic Behavioral and Social Science ,Behavioral and Social Science ,Neurosciences ,Mind and Body ,Mental Health ,Mental health ,Good Health and Well Being ,Humans ,Gastrointestinal Microbiome ,Brain ,Inflammation ,Cognition ,Anxiety ,Brain resting state ,Discrimination ,Gut microbiome ,Psychological symptoms ,Systems biology ,Biological Sciences ,Medical and Health Sciences ,Psychology and Cognitive Sciences ,Psychiatry ,Biological sciences ,Biomedical and clinical sciences - Abstract
BackgroundDiscrimination is associated with negative health outcomes as mediated in part by chronic stress, but a full understanding of the biological pathways is lacking. Here we investigate the effects of discrimination involved in dysregulating the brain-gut microbiome (BGM) system.MethodsA total of 154 participants underwent brain magnetic resonance imaging to measure functional connectivity. Fecal samples were obtained for 16S ribosomal RNA profiling and fecal metabolites and serum for inflammatory markers, along with questionnaires. The Everyday Discrimination Scale was administered to measure chronic and routine experiences of unfair treatment. A sparse partial least squares-discriminant analysis was conducted to predict BGM alterations as a function of discrimination, controlling for sex, age, body mass index, and diet. Associations between discrimination-related BGM alterations and psychological variables were assessed using a tripartite analysis.ResultsDiscrimination was associated with anxiety, depression, and visceral sensitivity. Discrimination was associated with alterations of brain networks related to emotion, cognition and self-perception, and structural and functional changes in the gut microbiome. BGM discrimination-related associations varied by race/ethnicity. Among Black and Hispanic individuals, discrimination led to brain network changes consistent with psychological coping and increased systemic inflammation. For White individuals, discrimination was related to anxiety but not inflammation, while for Asian individuals, the patterns suggest possible somatization and behavioral (e.g., dietary) responses to discrimination.ConclusionsDiscrimination is attributed to changes in the BGM system more skewed toward inflammation, threat response, emotional arousal, and psychological symptoms. By integrating diverse lines of research, our results demonstrate evidence that may explain how discrimination contributes to health inequalities.
- Published
- 2023
8. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis
- Author
-
Kuraji, Ryutaro, Shiba, Takahiko, Dong, Tien S, Numabe, Yukihiro, and Kapila, Yvonne L
- Subjects
Biomedical and Clinical Sciences ,Dentistry ,Dental/Oral and Craniofacial Disease ,Nutrition ,Chronic Liver Disease and Cirrhosis ,Hepatitis ,Liver Disease ,Rare Diseases ,Digestive Diseases ,2.1 Biological and endogenous factors ,Aetiology ,Oral and gastrointestinal ,Good Health and Well Being ,Animals ,Dysbiosis ,Fibrosis ,Inflammation ,Liver ,Metabolic Syndrome ,Microbiota ,Non-alcoholic Fatty Liver Disease ,Periodontitis ,Intestines ,Periodontal disease ,Nonalcoholic fatty liver disease ,Metabolic syndrome ,Probiotics ,Clinical Sciences ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
A growing body of evidence from multiple areas proposes that periodontal disease, accompanied by oral inflammation and pathological changes in the microbiome, induces gut dysbiosis and is involved in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). A subgroup of NAFLD patients have a severely progressive form, namely nonalcoholic steatohepatitis (NASH), which is characterized by histological findings that include inflammatory cell infiltration and fibrosis. NASH has a high risk of further progression to cirrhosis and hepatocellular carcinoma. The oral microbiota may serve as an endogenous reservoir for gut microbiota, and transport of oral bacteria through the gastro-intestinal tract can set up a gut microbiome dysbiosis. Gut dysbiosis increases the production of potential hepatotoxins, including lipopolysaccharide, ethanol, and other volatile organic compounds such as acetone, phenol and cyclopentane. Moreover, gut dysbiosis increases intestinal permeability by disrupting tight junctions in the intestinal wall, leading to enhanced translocation of these hepatotoxins and enteric bacteria into the liver through the portal circulation. In particular, many animal studies support that oral administration of Porphyromonas gingivalis, a typical periodontopathic bacterium, induces disturbances in glycolipid metabolism and inflammation in the liver with gut dysbiosis. NAFLD, also known as the hepatic phenotype of metabolic syndrome, is strongly associated with metabolic complications, such as obesity and diabetes. Periodontal disease also has a bidirectional relationship with metabolic syndrome, and both diseases may induce oral and gut microbiome dysbiosis with insulin resistance and systemic chronic inflammation cooperatively. In this review, we will describe the link between periodontal disease and NAFLD with a focus on basic, epidemiological, and clinical studies, and discuss potential mechanisms linking the two diseases and possible therapeutic approaches focused on the microbiome. In conclusion, it is presumed that the pathogenesis of NAFLD involves a complex crosstalk between periodontal disease, gut microbiota, and metabolic syndrome. Thus, the conventional periodontal treatment and novel microbiome-targeted therapies that include probiotics, prebiotics and bacteriocins would hold great promise for preventing the onset and progression of NAFLD and subsequent complications in patients with periodontal disease.
- Published
- 2023
9. Microbiota-Dependent Upregulation of Bitter Taste Receptor Subtypes in the Mouse Large Intestine in High-Fat Diet-Induced Obesity
- Author
-
Caremoli, Filippo, Huynh, Jennifer, Lagishetty, Venu, Markovic, Daniela, Braun, Jonathan, Dong, Tien S, Jacobs, Jonathan P, and Sternini, Catia
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Clinical Sciences ,Prevention ,Digestive Diseases ,Obesity ,Nutrition ,Genetics ,Oral and gastrointestinal ,Cancer ,Male ,Female ,Mice ,Animals ,Diet ,High-Fat ,Taste ,Up-Regulation ,Gastrointestinal Microbiome ,Mice ,Inbred C57BL ,Cecum ,Microbiota ,Dysbiosis ,antibiotics ,dysbiosis ,gut ,microbiome ,enteroendocrine cells ,peptides ,hormones ,Food Sciences ,Clinical sciences ,Nutrition and dietetics ,Public health - Abstract
Bitter taste receptors (Tas2rs in mice) detect bitterness, a warning signal for toxins and poisons, and are expressed in enteroendocrine cells. We tested the hypothesis that Tas2r138 and Tas2r116 mRNAs are modulated by microbiota alterations induced by a long-term high-fat diet (HFD) and antibiotics (ABX) (ampicillin and neomycin) administered in drinking water. Cecum and colon specimens and luminal contents were collected from C57BL/6 female and male mice for qRT-PCR and microbial luminal 16S sequencing. HFD with/without ABX significantly increased body weight and fat mass at 4, 6, and 8 weeks. Tas2r138 and Tas2r116 mRNAs were significantly increased in mice fed HFD for 8 weeks vs. normal diet, and this increase was prevented by ABX. There was a distinct microbiota separation in each experimental group and significant changes in the composition and diversity of microbiome in mice fed a HFD with/without ABX. Tas2r mRNA expression in HFD was associated with several genera, particularly with Akkermansia, a Gram-negative mucus-resident bacterium. These studies indicate that luminal bacterial composition is affected by sex, diet, and ABX and support a microbial dependent upregulation of Tas2rs in HFD-induced obesity, suggesting an adaptive host response to specific diet-induced dysbiosis.
- Published
- 2023
10. Mediation of the association between disadvantaged neighborhoods and cortical microstructure by body mass index
- Author
-
Kilpatrick, Lisa A, Zhang, Keying, Dong, Tien S, Gee, Gilbert C, Beltran-Sanchez, Hiram, Wang, May, Labus, Jennifer S, Naliboff, Bruce D, Mayer, Emeran A, and Gupta, Arpana
- Subjects
Public Health ,Health Sciences ,Psychology ,Clinical Research ,Nutrition ,Neurosciences ,Basic Behavioral and Social Science ,Mental Health ,Behavioral and Social Science ,Aging - Abstract
BackgroundLiving in a disadvantaged neighborhood is associated with worse health outcomes, including brain health, yet the underlying biological mechanisms are incompletely understood. We investigated the relationship between neighborhood disadvantage and cortical microstructure, assessed as the T1-weighted/T2-weighted ratio (T1w/T2w) on magnetic resonance imaging, and the potential mediating roles of body mass index (BMI) and stress, as well as the relationship between trans-fatty acid intake and cortical microstructure.MethodsParticipants comprised 92 adults (27 men; 65 women) who underwent neuroimaging and provided residential address information. Neighborhood disadvantage was assessed as the 2020 California State area deprivation index (ADI). The T1w/T2w ratio was calculated at four cortical ribbon levels (deep, lower-middle, upper-middle, and superficial). Perceived stress and BMI were assessed as potential mediating factors. Dietary data was collected in 81 participants.ResultsHere, we show that worse ADI is positively correlated with BMI (r = 0.27, p = .01) and perceived stress (r = 0.22, p = .04); decreased T1w/T2w ratio in middle/deep cortex in supramarginal, temporal, and primary motor regions (p
- Published
- 2023
11. Improved psychosocial measures associated with physical activity may be explained by alterations in brain-gut microbiome signatures
- Author
-
Guan, Michelle, Dong, Tien S, Subramanyam, Vishvak, Guo, Yiming, Bhatt, Ravi R, Vaughan, Allison, Barry, Robert L, and Gupta, Arpana
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Health Sciences ,Medical Biochemistry and Metabolomics ,Psychology ,Nutrition ,Brain Disorders ,Clinical Research ,Basic Behavioral and Social Science ,Behavioral and Social Science ,Mental Health ,Obesity ,Neurosciences ,Underpinning research ,2.1 Biological and endogenous factors ,1.1 Normal biological development and functioning ,Aetiology ,Mental health ,Oral and gastrointestinal ,Stroke ,Good Health and Well Being ,Humans ,Gastrointestinal Microbiome ,Brain ,Microbiota ,Exercise - Abstract
Obesity contributes to physical comorbidities and mental health consequences. We explored whether physical activity could influence more than metabolic regulation and result in psychological benefits through the brain-gut microbiome (BGM) system in a population with high BMI. Fecal samples were obtained for 16 s rRNA profiling and fecal metabolomics, along with psychological and physical activity questionnaires. Whole brain resting-state functional MRI was acquired, and brain connectivity metrics were calculated. Higher physical activity was significantly associated with increased connectivity in inhibitory appetite control brain regions, while lower physical activity was associated with increased emotional regulation network connections. Higher physical activity was also associated with microbiome and metabolite signatures protective towards mental health and metabolic derangements. The greater resilience and coping, and lower levels of food addiction seen with higher physical activity, may be explained by BGM system differences. These novel findings provide an emphasis on the psychological and resilience benefits of physical activity, beyond metabolic regulation and these influences seem to be related to BGM interactions.
- Published
- 2023
12. Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes.
- Author
-
Jacobs, Jonathan P, Lagishetty, Venu, Hauer, Megan C, Labus, Jennifer S, Dong, Tien S, Toma, Ryan, Vuyisich, Momchilo, Naliboff, Bruce D, Lackner, Jeffrey M, Gupta, Arpana, Tillisch, Kirsten, and Mayer, Emeran A
- Subjects
Feces ,Humans ,Irritable Bowel Syndrome ,RNA ,Ribosomal ,16S ,Habits ,Gastrointestinal Microbiome ,Multiomics ,Biomarkers ,Bowel habit subtypes ,Irritable bowel syndrome ,Metabolomics ,Metatranscriptomics ,Microbiome ,Multi-omics ,Pain Research ,Digestive Diseases ,Nutrition ,Human Genome ,Clinical Research ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Oral and gastrointestinal ,Ecology ,Microbiology ,Medical Microbiology - Abstract
BackgroundIrritable bowel syndrome (IBS) is a common gastrointestinal disorder that is thought to involve alterations in the gut microbiome, but robust microbial signatures have been challenging to identify. As prior studies have primarily focused on composition, we hypothesized that multi-omics assessment of microbial function incorporating both metatranscriptomics and metabolomics would further delineate microbial profiles of IBS and its subtypes.MethodsFecal samples were collected from a racially/ethnically diverse cohort of 495 subjects, including 318 IBS patients and 177 healthy controls, for analysis by 16S rRNA gene sequencing (n = 486), metatranscriptomics (n = 327), and untargeted metabolomics (n = 368). Differentially abundant microbes, predicted genes, transcripts, and metabolites in IBS were identified by multivariate models incorporating age, sex, race/ethnicity, BMI, diet, and HAD-Anxiety. Inter-omic functional relationships were assessed by transcript/gene ratios and microbial metabolic modeling. Differential features were used to construct random forests classifiers.ResultsIBS was associated with global alterations in microbiome composition by 16S rRNA sequencing and metatranscriptomics, and in microbiome function by predicted metagenomics, metatranscriptomics, and metabolomics. After adjusting for age, sex, race/ethnicity, BMI, diet, and anxiety, IBS was associated with differential abundance of bacterial taxa such as Bacteroides dorei; metabolites including increased tyramine and decreased gentisate and hydrocinnamate; and transcripts related to fructooligosaccharide and polyol utilization. IBS further showed transcriptional upregulation of enzymes involved in fructose and glucan metabolism as well as the succinate pathway of carbohydrate fermentation. A multi-omics classifier for IBS had significantly higher accuracy (AUC 0.82) than classifiers using individual datasets. Diarrhea-predominant IBS (IBS-D) demonstrated shifts in the metatranscriptome and metabolome including increased bile acids, polyamines, succinate pathway intermediates (malate, fumarate), and transcripts involved in fructose, mannose, and polyol metabolism compared to constipation-predominant IBS (IBS-C). A classifier incorporating metabolites and gene-normalized transcripts differentiated IBS-D from IBS-C with high accuracy (AUC 0.86).ConclusionsIBS is characterized by a multi-omics microbial signature indicating increased capacity to utilize fermentable carbohydrates-consistent with the clinical benefit of diets restricting this energy source-that also includes multiple previously unrecognized metabolites and metabolic pathways. These findings support the need for integrative assessment of microbial function to investigate the microbiome in IBS and identify novel microbiome-related therapeutic targets. Video Abstract.
- Published
- 2023
13. Obesity is associated with a distinct brain-gut microbiome signature that connects Prevotella and Bacteroides to the brain’s reward center
- Author
-
Dong, Tien S, Guan, Michelle, Mayer, Emeran A, Stains, Jean, Liu, Cathy, Vora, Priten, Jacobs, Jonathan P, Lagishetty, Venu, Chang, Lin, Barry, Robert L, and Gupta, Arpana
- Subjects
Microbiology ,Biological Sciences ,Neurosciences ,Behavioral and Social Science ,Obesity ,Nutrition ,Basic Behavioral and Social Science ,Prevention ,Oral and gastrointestinal ,Bacteroides ,Brain ,Feces ,Female ,Gastrointestinal Microbiome ,Humans ,Male ,Prevotella ,RNA ,Ribosomal ,16S ,Reward ,Tryptophan ,Brain-Gut-Microbiome ,nucleus accumbens - Abstract
The prevalence of obesity has risen to its highest values over the last two decades. While many studies have either shown brain or microbiome connections to obesity, few have attempted to analyze the brain-gut-microbiome relationship in a large cohort adjusting for cofounders. Therefore, we aim to explore the connection of the brain-gut-microbiome axis to obesity controlling for such cofounders as sex, race, and diet. Whole brain resting state functional MRI was acquired, and connectivity and brain network properties were calculated. Fecal samples were obtained from 287 obese and non-obese participants (males n = 99, females n = 198) for 16s rRNA profiling and fecal metabolites, along with a validated dietary questionnaire. Obesity was associated with alterations in the brain's reward network (nucleus accumbens, brainstem). Microbial diversity (p = .03) and composition (p = .03) differed by obesity independent of sex, race, or diet. Obesity was associated with an increase in Prevotella/Bacteroides (P/B) ratio and a decrease in fecal tryptophan (p = .02). P/B ratio was positively correlated to nucleus accumbens centrality (p = .03) and negatively correlated to fecal tryptophan (p = .004). Being Hispanic, eating a standard American diet, having a high Prevotella/Bacteroides ratio, and a high nucleus accumbens centrality were all independent risk factors for obesity. There are obesity-related signatures in the BGM-axis independent of sex, race, and diet. Race, diet, P/B ratio and increased nucleus accumbens centrality were independent risk factors for obesity. P/B ratio was inversely related to fecal tryptophan, a metabolite related to serotonin biosynthesis, and positively related to nucleus accumbens centrality, a region central to the brain's reward center. These findings may expand the field of therapies for obesity through novel pathways directed at the BGM axis.
- Published
- 2022
14. Duodenal Microbiome and Serum Metabolites Predict Hepatocellular Carcinoma in a Multicenter Cohort of Patients with Cirrhosis
- Author
-
Dong, Tien S, Jacobs, Jonathan P, Agopian, Vatche, Pisegna, Joseph R, Ayoub, Walid, Durazo, Francisco, Enayati, Pedram, Sundaram, Vinay, Benhammou, Jihane N, Noureddin, Mazen, Choi, Gina, Lagishetty, Venu, Fiehn, Oliver, Goodman, Marc T, Elashoff, David, and Hussain, Shehnaz K
- Subjects
Medical Biochemistry and Metabolomics ,Biomedical and Clinical Sciences ,Liver Cancer ,Chronic Liver Disease and Cirrhosis ,Rare Diseases ,Clinical Research ,Genetics ,Cancer ,Liver Disease ,Human Genome ,Digestive Diseases ,Good Health and Well Being ,Carcinoma ,Hepatocellular ,Humans ,Liver Cirrhosis ,Liver Neoplasms ,Male ,Methionine ,Microbiota ,Proportional Hazards Models ,Prospective Studies ,Risk Factors ,Taurocholic Acid ,Bile acids ,Biogenic amines ,Alloprevotella ,Taurocholic acid ,Time-to-event ,Small intestine ,Clinical Sciences ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
BackgroundHepatocellular carcinoma (HCC) is rapidly increasing in the U.S. and is a leading cause of mortality for patients with cirrhosis. Discovering novel biomarkers for risk stratification of HCC is paramount. We examined biomarkers of the gut-liver axis in a prospective multicenter cohort.MethodsPatients with cirrhosis without a history of HCC were recruited between May 2015 and March 2020 and prospectively followed at 3 tertiary care hospitals in Los Angeles. Microbiome analysis was performed on duodenal biopsies and metabolomic analysis was performed on serum samples, collected at the time of enrollment. Optimal microbiome-based survival analysis and Cox proportional hazards regression analysis were used to determine microbiota and metabolite associations with HCC development, respectively.ResultsA total of 227 participants with liver cirrhosis contributed a total of 459.58 person-years of follow-up, with 14 incident HCC diagnoses. Male sex (HR = 7.06, 95% CI = 1.02-54.86) and baseline hepatic encephalopathy (HE, HR = 4.65, 95% CI = 1.60-13.52) were associated with developing HCC over follow-up. Adjusting for age, sex, baseline HE, and alkaline phosphatase, an increased risk of HCC were observed for participants with the highest versus lowest three quartiles for duodenal Alloprevotella (HR = 3.22, 95% CI = 1.06-9.73) and serum taurocholic acid (HR = 6.87, 95% CI = 2.32-20.27), methionine (HR = 9.97, 95% CI = 3.02-32.94), and methioninesulfoxide (HR = 5.60, 95% CI = 1.84-17.10). Being in the highest quartile for Alloprevotella or methionine had a sensitivity and specificity for developing HCC of 85.71% and 60.56%, respectively, with an odds ratio of 10.92 (95% CI = 2.23-53.48).ConclusionAlloprevotella and methionine, methioninesulfoxide, and taurocholic acid predicted future HCC development in a high-risk population of participants with liver cirrhosis.
- Published
- 2022
15. Subchronic inhalation exposure to ultrafine particulate matter alters the intestinal microbiome in various mouse models
- Author
-
Chang, Candace, Gupta, Rajat, Sedighian, Farzaneh, Louie, Allen, Gonzalez, David M., Le, Collin, Cho, Jae Min, Park, Seul-Ki, Castellanos, Jocelyn, Ting, To-Wei, Dong, Tien S., Arias-Jayo, Nerea, Lagishetty, Venu, Navab, Mohamad, Reddy, Srinivasa, Sioutas, Constantinos, Hsiai, Tzung, Jacobs, Jonathan P., and Araujo, Jesus A.
- Published
- 2024
- Full Text
- View/download PDF
16. Leveraging the Microbiome for Obesity: Moving From Form to Function
- Author
-
Lee, Anna H, Manly, Amanda, and Dong, Tien S
- Subjects
Medical Biochemistry and Metabolomics ,Biomedical and Clinical Sciences ,Prevention ,Obesity ,Nutrition ,Digestive Diseases ,Complementary and Integrative Health ,Oral and gastrointestinal ,Metabolic and endocrine ,Bacteria ,Fatty Acids ,Volatile ,Gastrointestinal Microbiome ,Humans ,Microbiota ,gut ,microbiome ,microbiota ,obesity ,weight ,Clinical Sciences ,Nutrition and Dietetics ,Clinical sciences - Abstract
Treatment of obesity, an ongoing global epidemic, is challenging, as weight-loss efforts require a multidisciplinary approach addressing both behavioral and biologic needs that are not completely understood. Recent studies of the gut microbiome may provide better insight into the condition, and ultimately serve to advance more effective therapies. Research in this field has shifted from analyzing microbiome compositional differences to investigating functional changes that affect disease pathophysiology and outcome. Bacteria-derived metabolites are a way to bridge compositional changes to functional consequences. Through the production of metabolites, such as short chain fatty acids, tryptophan derivatives and bile acids, and interactions with peripheral and central signaling pathways, the gut microbiome may alter the body's metabolic and behavioral responses to food. Here, we summarize these mechanisms driven by gut-derived metabolites, through which the microbiome is thought to contribute to obesity, as well as review recent investigations of interventions related to these metabolites. Limitations of existing research, primarily due to paucity of causal studies in humans, are also discussed in this review.
- Published
- 2022
17. The Interplay of the Renin-Angiotensin System and Solid Organ Transplantation
- Author
-
Dery, Kenneth J., Kupiec-Weglinski, Jerzy W., Dong, Tien S., Dhalla, Naranjan S., Series Editor, Bolli, Roberto, Editorial Board Member, Goyal, Ramesh, Editorial Board Member, Kartha, Chandrasekharan, Editorial Board Member, Kirshenbaum, Lorrie, Editorial Board Member, Makino, Naoki, Editorial Board Member, Mehta, Jawahar L. L., Editorial Board Member, Ostadal, Bohuslav, Editorial Board Member, Pierce, Grant N., Editorial Board Member, Slezak, Jan, Editorial Board Member, Varro, Andras, Editorial Board Member, Werdan, Karl, Editorial Board Member, Weglicki, William B., Editorial Board Member, Bhullar, Sukhwinder K., editor, and Tappia, Paramjit S., editor
- Published
- 2023
- Full Text
- View/download PDF
18. Advances in Brain–Gut–Microbiome Interactions: A Comprehensive Update on Signaling Mechanisms, Disorders, and Therapeutic Implications
- Author
-
Dong, Tien S. and Mayer, Emeran
- Published
- 2024
- Full Text
- View/download PDF
19. The Ocular Microbiome Is Altered by Sampling Modality and Age
- Author
-
Katzka, William, Dong, Tien S, Luu, Kayti, Lagishetty, Venu, Sedighian, Farzaneh, Arias-Jayo, Nerea, Jacobs, Jonathan P, and Hsu, Hugo Y
- Subjects
Genetics ,Eye Disease and Disorders of Vision ,Clinical Research ,Human Genome ,Eye ,Aged ,Bacteria ,Cornea ,Humans ,Microbiota ,RNA ,Ribosomal ,16S ,Specimen Handling ,cornea ,ocular surface ,microbiome ,calcium alginate swab ,epithelial biopsy ,cotton swab ,Weck-Cel ,Biomedical Engineering ,Opthalmology and Optometry - Abstract
BackgroundStudies of the ocular microbiome have used a variety of sampling techniques, but no study has directly compared different sampling methods applied to the same eyes to one another or to a reference standard of corneal epithelial biopsy. We addressed this lack by comparing the microbiome from three conjunctival swabs with those of corneal epithelial biopsy.MethodsTwelve eyes (11 patients) were swabbed by calcium alginate swab, cotton-tipped applicator, and Weck-Cel cellulose sponge before a corneal epithelial biopsy (48 samples). We then performed 16S rRNA gene sequencing and universal 16S rRNA gene real-time polymerase chain reaction. Negative/blank controls were used to eliminate contaminants. An analysis was performed to examine the concordance of the three swab types to corneal epithelial biopsy. The effect of patient age on the ocular microbiome as determined by epithelial biopsy was also examined.ResultsThe ocular microbiome from corneal epithelial biopsies consisted of 31 genera with a relative abundance of 1% or more, including Weisella, Corynebacterium, and Pseudomonas. Of the three swab types, Weck-Cel differed the most from corneal biopsies based on beta-diversity analysis. Cotton swabs were unable to capture the Bacteroides population seen on epithelial biopsy. Therefore, calcium alginate swabs seemed to be the closest to epithelial biopsies. Older patients (≥65 years old) had higher alpha diversity (P < 0.05) than younger patients. Differential abundance testing showed that there were 18 genera that were differentially abundant between the two age groups, including Streptococcus and eight members of the Proteobacteria phylum.ConclusionsWe demonstrate that ocular sampling method and patient age can greatly affect the outcome of sequencing-based analysis of the ocular microbiome.Translational relevanceBy understanding the impact of different sampling methods on the results obtained from the ocular surface microbiome, future research on the topic will be more reproducible, leading to a better understanding of ocular surface microbiome in health and disease.
- Published
- 2021
20. Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease.
- Author
-
Dong, Tien S, Luu, Kayti, Lagishetty, Venu, Sedighian, Farzaneh, Woo, Shih-Lung, Dreskin, Benjamin W, Katzka, William, Chang, Candace, Zhou, Yi, Arias-Jayo, Nerea, Yang, Julianne, Ahdoot, Aaron I, Ye, Jason, Li, Zhaoping, Pisegna, Joseph R, and Jacobs, Jonathan P
- Subjects
Metabolic syndrome ,advanced steatosis ,diabetes ,microbiome ,nonalcoholic fatty liver disease ,obesity ,ultrasound elastography ,Genetics ,Clinical Research ,Nutrition ,Diabetes ,Cardiovascular ,Liver Disease ,Chronic Liver Disease and Cirrhosis ,Digestive Diseases ,Aetiology ,2.1 Biological and endogenous factors ,Metabolic and endocrine - Abstract
AimThe microbiome has been shown to be pivotal in the development of metabolic associated fatty liver disease (MAFLD). Few have examined the relationship of the microbiome specifically with steatosis grade. Therefore, our aim was to characterize the association of the microbiome with MAFLD steatosis severity while adjusting for metabolic comorbidities including diabetes.MethodsWe enrolled patients with MAFLD at the West Los Angeles Veterans Affair Hospital. All patients underwent ultrasound elastography, fasting serum collection, and fecal sampling for 16S sequencing. We examined the associations of microbial diversity and composition with advanced steatosis, defined as a CAP score of ≥ 300 dB/m, with or without the presence of metabolic comorbidities.ResultsSeventy-five patients were enrolled. African American were less likely to have advanced steatosis than either Hispanics or Whites (P = 0.001). Patients with more advanced steatosis had higher fasting serum triglyceride (192.6 ± 157.1 mg/dL vs. 122.5 ± 57.4 mg/dL), HbA1c (6.7% ± 1.4% vs. 6.1% ± 0.8%), transaminases, and were more likely to have metabolic syndrome (52.4% vs. 24.2%, P = 0.02). Advanced steatosis and diabetes were associated with altered microbial composition. Bacteroides was negatively associated with advanced steatosis while Megasphaera was positively associated with steatosis. Akkermansia was negatively associated with diabetes, while Anaerostipes and Parabacteroides were positively associated with diabetes.ConclusionDiabetes and metabolic syndrome are associated with hepatic steatosis severity in MAFLD patients and both advanced steatosis and comorbid diabetes are independently associated with microbiome changes. These results provide insight into the role of the gut microbiome in MAFLD associated with metabolic syndrome.
- Published
- 2021
21. The Intestinal Microbiome Predicts Weight Loss on a Calorie-Restricted Diet and Is Associated With Improved Hepatic Steatosis.
- Author
-
Dong, Tien S, Luu, Kayti, Lagishetty, Venu, Sedighian, Farzaneh, Woo, Shih-Lung, Dreskin, Benjamin W, Katzka, William, Chang, Candace, Zhou, Yi, Arias-Jayo, Nerea, Yang, Julianne, Ahdoot, Aaron I, Ye, Jason, Li, Zhaoping, Pisegna, Joseph R, and Jacobs, Jonathan P
- Subjects
controlled attenuated parameter ,metabolic associated fatty liver disease ,metabolic syndrome ,microbiome ,obesity ,ultrasound elastography ,Prevention ,Digestive Diseases ,Nutrition ,Clinical Research ,Liver Disease ,Chronic Liver Disease and Cirrhosis ,Obesity ,Clinical Trials and Supportive Activities ,Evaluation of treatments and therapeutic interventions ,6.7 Physical ,Aetiology ,2.1 Biological and endogenous factors ,Cardiovascular ,Cancer ,Oral and gastrointestinal ,Metabolic and endocrine ,Agricultural Biotechnology ,Nutrition and Dietetics - Abstract
Background: The microbiome has been shown in pre-clinical and epidemiological studies to be important in both the development and treatment of obesity and metabolic associated fatty liver disease (MAFLD). However, few studies have examined the role of the microbiome in the clinical response to calorie restriction. To explore this area, we performed a prospective study examining the association of the intestinal microbiome with weight loss and change in hepatic steatosis on a calorie-restricted diet. Methods: A prospective dietary intervention study of 80 overweight and obese participants was performed at the Greater West Los Angeles Veterans Affair Hospital. Patients were placed on a macronutrient standardized diet for 16 weeks, including 14 weeks of calorie restriction (500 calorie deficit). Body composition analysis by impedance, plasma lipid measurements, and ultrasound elastography to measure hepatic steatosis were performed at baseline and week 16. Intestinal microbiome composition was assessed using 16S rRNA gene sequencing. A per protocol analysis was performed on all subjects completing the trial (n = 46). Results: Study completers showed significant reduction in weight, body mass index, total cholesterol, low density lipoprotein, and triglyceride. Subjects who lost at least 5% of their body weight had significantly greater reduction in serum triglyceride and hepatic steatosis than those with
- Published
- 2021
22. The Interplay of the Renin-Angiotensin System and Solid Organ Transplantation
- Author
-
Dery, Kenneth J., primary, Kupiec-Weglinski, Jerzy W., additional, and Dong, Tien S., additional
- Published
- 2023
- Full Text
- View/download PDF
23. Shifts in microbial diversity, composition, and functionality in the gut and genital microbiome during a natural SIV infection in vervet monkeys
- Author
-
Jasinska, Anna J, Dong, Tien S, Lagishetty, Venu, Katzka, William, Jacobs, Jonathan P, Schmitt, Christopher A, Cramer, Jennifer Danzy, Ma, Dongzhu, Coetzer, Willem G, Grobler, J Paul, Turner, Trudy R, Freimer, Nelson, Pandrea, Ivona, and Apetrei, Cristian
- Subjects
Microbiology ,Biological Sciences ,Genetics ,HIV/AIDS ,Infectious Diseases ,Prevention ,2.1 Biological and endogenous factors ,Aetiology ,2.2 Factors relating to the physical environment ,Infection ,Good Health and Well Being ,Animals ,Bacteria ,Chlorocebus aethiops ,Feces ,Female ,Gastrointestinal Microbiome ,Male ,Microbiota ,Monkey Diseases ,Rectum ,Simian Acquired Immunodeficiency Syndrome ,Simian Immunodeficiency Virus ,Vagina ,SIV ,Microbiome ,Proteobacteria ,Succinivibrio ,Acute infection ,Primate ,Simian immunodeficiency virus ,Ecology ,Medical Microbiology ,Evolutionary biology - Abstract
BackgroundThe microbiota plays an important role in HIV pathogenesis in humans. Microbiota can impact health through several pathways such as increasing inflammation in the gut, metabolites of bacterial origin, and microbial translocation from the gut to the periphery which contributes to systemic chronic inflammation and immune activation and the development of AIDS. Unlike HIV-infected humans, SIV-infected vervet monkeys do not experience gut dysfunction, microbial translocation, and chronic immune activation and do not progress to immunodeficiency. Here, we provide the first reported characterization of the microbial ecosystems of the gut and genital tract in a natural nonprogressing host of SIV, wild vervet monkeys from South Africa.ResultsWe characterized fecal, rectal, vaginal, and penile microbiomes in vervets from populations heavily infected with SIV from diverse locations across South Africa. Geographic site, age, and sex affected the vervet microbiome across different body sites. Fecal and vaginal microbiome showed marked stratification with three enterotypes in fecal samples and two vagitypes, which were predicted functionally distinct within each body site. External bioclimatic factors, biome type, and environmental temperature influenced microbiomes locally associated with vaginal and rectal mucosa. Several fecal microbial taxa were linked to plasma levels of immune molecules, for example, MIG was positively correlated with Lactobacillus and Escherichia/Shigella and Helicobacter, and IL-10 was negatively associated with Erysipelotrichaceae, Anaerostipes, Prevotella, and Anaerovibrio, and positively correlated with Bacteroidetes and Succinivibrio. During the chronic phase of infection, we observed a significant increase in gut microbial diversity, alterations in community composition (including a decrease in Proteobacteria/Succinivibrio in the gut) and functionality (including a decrease in genes involved in bacterial invasion of epithelial cells in the gut), and partial reversibility of acute infection-related shifts in microbial abundance observed in the fecal microbiome. As part of our study, we also developed an accurate predictor of SIV infection using fecal samples.ConclusionsThe vervets infected with SIV and humans infected with HIV differ in microbial responses to infection. These responses to SIV infection may aid in preventing microbial translocation and subsequent disease progression in vervets, and may represent host microbiome adaptations to the virus. Video Abstract.
- Published
- 2020
24. A High Protein Calorie Restriction Diet Alters the Gut Microbiome in Obesity.
- Author
-
Dong, Tien S, Luu, Kayti, Lagishetty, Venu, Sedighian, Farzaneh, Woo, Shih-Lung, Dreskin, Benjamin W, Katzka, William, Chang, Candace, Zhou, Yi, Arias-Jayo, Nerea, Yang, Julianne, Ahdoot, Aaron, Li, Zhaoping, Pisegna, Joseph R, and Jacobs, Jonathan P
- Subjects
Feces ,Humans ,Obesity ,Dietary Carbohydrates ,Caloric Restriction ,Diet ,Reducing ,Energy Intake ,Dietary Fiber ,Adult ,Aged ,Middle Aged ,Female ,Male ,Gastrointestinal Microbiome ,Diet ,High-Protein ,calorie restriction ,high protein diet ,microbiome ,obesity ,randomized controlled trial ,Nutrition ,Clinical Research ,Prevention ,6.7 Physical ,Cardiovascular ,Cancer ,Stroke ,Metabolic and endocrine ,Oral and gastrointestinal ,Food Sciences ,Nutrition and Dietetics - Abstract
BackgroundHigh protein calorie restriction diets have shown clinical efficacy for obesity, but the mechanisms are not fully known. The intestinal microbiome is a mediator of obesity and preclinical data support an effect of high protein diet (HPD) on the gut microbiome of obesity, but there are few studies in humans.MethodsTo address this, we conducted a dietary intervention trial of 80 overweight and obese subjects who were randomized to a calorie-restricted high protein diet (HPD) (30% calorie intake) or calorie-restricted normal protein diet (NPD) (15%) for 8 weeks. Baseline dietary intake patterns were assessed by the Diet History Questionnaire III. Longitudinal fecal sampling was performed at baseline, week 1, week 2, week 4, week 6, and week 8, for a total of 365 samples. Intestinal microbiome composition was assessed by 16S rRNA gene sequencing.ResultsAt baseline, microbial composition was associated with fiber and protein intake. Subjects on the HPD showed a significant increase in microbial diversity as measured by the Shannon index compared to those on the NPD. The HPD was also associated with significant differences in microbial composition after treatment compared to the NPD. Both diets induced taxonomic shifts compared to baseline, including enrichment of Akkermansia spp. and Bifidobacterium spp. and depletion of Prevotella spp. Conclusion: These findings provide evidence that weight loss diets alter the gut microbiome in obesity and suggest differential effects of HPDs compared to NPDs which may influence the clinical response to HPD.
- Published
- 2020
25. A Distinct Brain‐Gut‐Microbiome Profile Exists for Females with Obesity and Food Addiction
- Author
-
Dong, Tien S, Mayer, Emeran A, Osadchiy, Vadim, Chang, Candace, Katzka, William, Lagishetty, Venu, Gonzalez, Kimberly, Kalani, Amir, Stains, Jean, Jacobs, Jonathan P, Longo, Valter D, and Gupta, Arpana
- Subjects
Medical Biochemistry and Metabolomics ,Biomedical and Clinical Sciences ,Brain Disorders ,Nutrition ,Digestive Diseases ,Obesity ,Neurosciences ,Aetiology ,2.1 Biological and endogenous factors ,Oral and gastrointestinal ,Good Health and Well Being ,Adolescent ,Adult ,Brain ,Female ,Food Addiction ,Gastrointestinal Microbiome ,Humans ,Metabolomics ,Middle Aged ,Young Adult ,Endocrinology & Metabolism - Abstract
BackgroundAlterations in brain-gut-microbiome interactions have been implicated as an important factor in obesity. This study aimed to explore the relationship between food addiction (FA) and the brain-gut-microbiome axis, using a multi-omics approach involving microbiome data, metabolomics, and brain imaging.MethodsBrain magnetic resonance imaging was obtained in 105 females. FA was defined by using the Yale Food Addiction Scale. Fecal samples were collected for sequencing and metabolomics. Statistical analysis was done by using multivariate analyses and machine learning algorithms.ResultsOf the females with obesity, 33.3% exhibited FA as compared with 5.3% and 0.0% of females with overweight and normal BMI, respectively (P = 0.0001). Based on a multilevel sparse partial least square discriminant analysis, there was a difference in the gut microbiome of females with FA versus those without. Differential abundance testing showed Bacteroides, Megamonas, Eubacterium, and Akkermansia were statistically associated with FA (q
- Published
- 2020
26. A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD.
- Author
-
Dong, Tien S, Katzka, William, Lagishetty, Venu, Luu, Kayti, Hauer, Meg, Pisegna, Joseph, and Jacobs, Jonathan P
- Subjects
Liver ,Feces ,Humans ,Prevotella ,Liver Cirrhosis ,Severity of Illness Index ,Adult ,Aged ,Middle Aged ,Female ,Male ,End Stage Liver Disease ,Non-alcoholic Fatty Liver Disease ,Gastrointestinal Microbiome ,Infectious Diseases ,Digestive Diseases ,Liver Disease ,Clinical Research ,Hepatitis ,Chronic Liver Disease and Cirrhosis ,Substance Misuse ,Alcoholism ,Alcohol Use and Health ,Detection ,screening and diagnosis ,4.1 Discovery and preclinical testing of markers and technologies ,Aetiology ,2.1 Biological and endogenous factors ,Oral and gastrointestinal ,Good Health and Well Being - Abstract
The presence of advanced fibrosis is an important measure of the severity of chronic liver disease. Prior works that have examined the gut microbiome as a novel biomarker for advanced fibrosis have only examined patients with nonalcoholic fatty liver disease. Therefore, our goal was to examine the gut microbiome across varying etiologies of liver disease to create a predictive model for liver fibrosis based upon a microbial signature. Stool samples were obtained from patients with chronic liver disease (n = 50) undergoing FibroScan (ultrasound elastography) at the VA Greater Los Angeles Healthcare System. Healthy control patients (n = 25) were also recruited as a reference population. Fecal samples underwent 16S ribosomal RNA sequencing. Using differentially abundant microbes, a random forest classifier model was created to distinguish advanced fibrosis from mild/moderate fibrosis. The findings were then validated in a separate cohort of chronic liver disease patients (n = 37). Etiologies for liver disease included non-alcoholic liver disease (58.0%), hepatitis C (26.0%), hepatitis B (10.0%), and alcohol (6.0%). Microbiome composition was distinct in liver patients with advanced fibrosis compared to those with minimal fibrosis and healthy controls (p = 0.003). In multivariate negative binomial modeling, 26 bacterial taxa were differentially abundant in patients with advanced fibrosis as compared to those with minimal/moderate fibrosis (q-value
- Published
- 2020
27. Understanding the Heterogeneity of Obesity and the Relationship to the Brain-Gut Axis
- Author
-
Hung, Tony KW, Dong, Tien S, Chen, Zixi, Elashoff, David, Sinsheimer, Janet S, Jacobs, Jonathan P, Lagishetty, Venu, Vora, Priten, Stains, Jean, Mayer, Emeran A, and Gupta, Arpana
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Clinical Research ,Nutrition ,Obesity ,Neurosciences ,Oral and gastrointestinal ,Life Below Water ,Adolescent ,Adult ,Amino Acids ,Body Mass Index ,Brain ,Cross-Sectional Studies ,Diet ,Feces ,Female ,Gastrointestinal Microbiome ,Gastrointestinal Tract ,Hispanic or Latino ,Humans ,Male ,Metabolic Diseases ,Middle Aged ,Overweight ,RNA ,Ribosomal ,16S ,Sequence Analysis ,RNA ,Socioeconomic Factors ,Young Adult ,obesity ,microbiome ,brain-gut axis ,amino acids ,metabolites ,heterogeneity ,precision medicine ,Hispanic ,health disparity ,diet ,Food Sciences ,Clinical sciences ,Nutrition and dietetics ,Public health - Abstract
Obesity is best understood as a multifactorial metabolic imbalances disorder. In a cross-sectional study, we aimed to explore sociodemographic and dietary determinants of obesity in relation to brain-gut homeostasis among overweight and obese individuals. Multivariate logistic regression models were used to examine obesity and its association with sociodemographic and dietary factors. Biological variables examined included the gut microbiome, fecal amino acid metabolites and brain structural volumes. Among 130 participants, there were higher odds of obesity if individuals were Hispanic (adjusted odds ratio (aOR) 1.56, p = 0.014). Compared to non-Hispanics, Hispanics differed in gut microbial composition (p = 0.046) with lower microbial species richness (Chao1) (p = 0.032) and evenness (Shannon) (p = 0.0029). Fourteen of the twenty fecal amino acids including branch-chain- and aromatic- amino acids were increased among Hispanics (q < 0.05). Brain structural volumes in reward regions were decreased in Hispanics (pallidum, q = 0.036; brainstem, q = 0.011). Correlation patterns suggest complex brain-gut interactions differ by Hispanic ethnicity. In conclusion, Hispanics expressed a unique brain-gut microbial signature, which was associated with obesity despite sociodemographic and dietary differences. Addressing ethnic disparities guided by biologic phenotypes may unlock novel understanding of obesity heterogeneity and treatment strategies.
- Published
- 2020
28. Dietary Protein, Fiber and Coffee Are Associated with Small Intestine Microbiome Composition and Diversity in Patients with Liver Cirrhosis
- Author
-
Hussain, Shehnaz K, Dong, Tien S, Agopian, Vatche, Pisegna, Joseph R, Durazo, Francisco A, Enayati, Pedram, Sundaram, Vinay, Benhammou, Jihane N, Noureddin, Mazen, Choi, Gina, Ayoub, Walid S, Lagishetty, Venu, Elashoff, David, Goodman, Marc T, and Jacobs, Jonathan P
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Clinical Sciences ,Liver Disease ,Genetics ,Prevention ,Nutrition ,Digestive Diseases ,Chronic Liver Disease and Cirrhosis ,Clinical Research ,Oral and gastrointestinal ,Life Below Water ,Coffee ,Cross-Sectional Studies ,Diet Surveys ,Diet ,Healthy ,Dietary Fiber ,Dietary Proteins ,Duodenum ,Eating ,Female ,Gastrointestinal Microbiome ,Humans ,Liver Cirrhosis ,Male ,Middle Aged ,Prospective Studies ,RNA ,Ribosomal ,16S ,liver cirrhosis ,duodenal microbiome ,diet ,Food Sciences ,Clinical sciences ,Nutrition and dietetics ,Public health - Abstract
: The gut microbiome is a key factor in chronic liver disease progression. In prior research, we found that the duodenal microbiome was associated with sex, ethnicity, and cirrhosis complications. Here, we examined the association between diet and the duodenal microbiome in patients with liver cirrhosis. This study included 51 participants who completed a detailed food frequency questionnaire and donated duodenal biopsies for microbiome characterization by 16S ribosomal RNA gene sequencing. Data were analyzed for alpha diversity, beta diversity, and association of taxa abundance with diet quality and components using QIIME 2 pipelines. Diet quality was assessed through calculation of the Healthy Eating Index 2010. Participants with higher adherence to protein recommendations exhibited increased microbial richness and evenness (p = 0.03) and a different microbial profile compared to those with lower adherence (p = 0.03). Prevotella-9 and Agathobacter were increased in association with increased protein adherence. Fiber consumption was also associated with the duodenal microbial profile (p = 0.01), with several taxa exhibiting significantly decreased or increased abundance in association with fiber intake. Coffee drinking was associated with microbial richness and evenness (p = 0.001), and there was a dose-response association between coffee drinking and relative abundance of Veillonella (p = 0.01). We conclude that protein, fiber, and coffee are associated with diversity and composition of the duodenal microbiome in liver cirrhosis.
- Published
- 2020
29. Improvement in Uncontrolled Eating Behavior after Laparoscopic Sleeve Gastrectomy Is Associated with Alterations in the Brain–Gut–Microbiome Axis in Obese Women
- Author
-
Dong, Tien S, Gupta, Arpana, Jacobs, Jonathan P, Lagishetty, Venu, Gallagher, Elizabeth, Bhatt, Ravi R, Vora, Priten, Osadchiy, Vadim, Stains, Jean, Balioukova, Anna, Chen, Yijun, Dutson, Erik, Mayer, Emeran A, and Sanmiguel, Claudia
- Subjects
Biomedical and Clinical Sciences ,Nutrition and Dietetics ,Clinical Sciences ,Behavioral and Social Science ,Prevention ,Brain Disorders ,Nutrition ,Digestive Diseases ,Obesity ,Clinical Research ,Neurosciences ,Oral and gastrointestinal ,Adolescent ,Adult ,Bariatric Surgery ,Brain ,Diet ,Female ,Food Addiction ,Gastrectomy ,Gastrointestinal Microbiome ,Health Behavior ,Humans ,Laparoscopy ,Magnetic Resonance Imaging ,Middle Aged ,Surveys and Questionnaires ,Weight Loss ,Young Adult ,bariatric surgery ,brain– ,gut– ,microbiome axis ,metabolite ,obesity ,brain ,brain–gut–microbiome axis ,Food Sciences ,Clinical sciences ,Nutrition and dietetics ,Public health - Abstract
BackgroundBariatric surgery is proven to change eating behavior and cause sustained weight loss, yet the exact mechanisms underlying these changes are not clearly understood. We explore this in a novel way by examining how bariatric surgery affects the brain-gut-microbiome (BGM) axis.MethodsPatient demographics, serum, stool, eating behavior questionnaires, and brain magnetic resonance imaging (MRI) were collected before and 6 months after laparoscopic sleeve gastrectomy (LSG). Differences in eating behavior and brain morphology and resting-state functional connectivity in core reward regions were correlated with serum metabolite and 16S microbiome data.ResultsLSG resulted in significant weight loss and improvement in maladaptive eating behaviors as measured by the Yale Food Addiction Scale (YFAS). Brain imaging showed a significant increase in brain volume of the putamen (p.adj < 0.05) and amygdala (p.adj < 0.05) after surgery. Resting-state connectivity between the precuneus and the putamen was significantly reduced after LSG (p.adj = 0.046). This change was associated with YFAS symptom count. Bacteroides, Ruminococcus, and Holdemanella were associated with reduced connectivity between these areas. Metabolomic profiles showed a positive correlation between this brain connection and a phosphatidylcholine metabolite.ConclusionBariatric surgery modulates brain networks that affect eating behavior, potentially through effects on the gut microbiota and its metabolites.
- Published
- 2020
30. Dietary Supplementation with Omega-3 Polyunsaturated Fatty Acids Reduces Opioid-Seeking Behaviors and Alters the Gut Microbiome.
- Author
-
Hakimian, Joshua K, Dong, Tien S, Barahona, Jorge A, Lagishetty, Venu, Tiwari, Suchi, Azani, Darien, Barrera, Matthew, Lee, Suhjin, Severino, Amie L, Mittal, Nitish, Cahill, Catherine M, Jacobs, Jonathan P, and Walwyn, Wendy M
- Subjects
DHA ,EPA ,Intravenous self-administration ,anxiety ,mice ,microbiome-brain axis ,opioid ,polyunsaturated fatty acids ,Nutrition and Dietetics - Abstract
Opioids are highly addictive substances with a relapse rate of over 90%. While preclinical models of chronic opioid exposure exist for studying opioid dependence, none recapitulate the relapses observed in human opioid addiction. The mechanisms associated with opioid dependence, the accompanying withdrawal symptoms, and the relapses that are often observed months or years after opioid dependence are poorly understood. Therefore, we developed a novel model of chronic opioid exposure whereby the level of administration is self-directed with periods of behavior acquisition, maintenance, and then extinction alternating with reinstatement. This profile arguably mirrors that seen in humans, with initial opioid use followed by alternating periods of abstinence and relapse. Recent evidence suggests that dietary interventions that reduce inflammation, including omega-3 polyunsaturated fatty acids (n-3 PUFAs), may reduce substance misuse liability. Using the self-directed intake model, we characterize the observed profile of opioid use and demonstrate that an n-3-PUFA-enriched diet ameliorates oxycodone-seeking behaviors in the absence of drug availability and reduces anxiety. Guided by the major role gut microbiota have on brain function, neuropathology, and anxiety, we profile the microbiome composition and the effects of chronic opioid exposure and n-3 PUFA supplementation. We demonstrate that the withdrawal of opioids led to a significant depletion in specific microbiota genera, whereas n-3 PUFA supplementation increased microbial richness, phylogenetic diversity, and evenness. Lastly, we examined the activation state of microglia in the striatum and found that n-3 PUFA supplementation reduced the basal activation state of microglia. These preclinical data suggest that a diet enriched in n-3 PUFAs could be used as a treatment to alleviate anxiety induced opioid-seeking behavior and relapse in human opioid addiction.
- Published
- 2019
31. Microbial Profiles of Cirrhosis in the Human Small Intestine.
- Author
-
Dong, Tien S, Jacobs, Jonathan P, and Hussain, Shehnaz K
- Subjects
Intestine ,Small ,Humans ,Hepatic Encephalopathy ,Hypertension ,Portal ,Liver Cirrhosis ,Bile Acids and Salts ,Gastrointestinal Microbiome ,Ascites ,Bile acids ,Cirrhosis ,Hepatic encephalopathy ,Microbiome ,Portal hypertension ,Human Genome ,Genetics ,Digestive Diseases ,Chronic Liver Disease and Cirrhosis ,Clinical Research ,Liver Disease ,2.1 Biological and endogenous factors ,Aetiology ,Oral and gastrointestinal ,Clinical Sciences ,Gastroenterology & Hepatology - Abstract
Purpose of reviewThe aim of this review is to summarize the recent literature on associations of small intestinal microbial and bile acid profiles with liver cirrhosis and its complications.Recent findingsRecent studies into the duodenal microbiome of patients with cirrhosis have linked the microbiome to certain etiologies of chronic liver disease as well as complications of cirrhosis. In particular, microbial differences in the duodenum of patients with cirrhosis have been linked to the presence of hepatic encephalopathy and varices. While the fecal microbiome of patients with liver cirrhosis is well characterized, the small intestinal microbiome of cirrhotic patients is an active area of research. This review focuses on the current understanding of the small intestinal microbiome in human cirrhosis as well as future directions of the field.
- Published
- 2019
32. Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
- Author
-
Dong, Tien S and Jacobs, Jonathan P
- Subjects
Microbiology ,Biological Sciences ,Biomedical and Clinical Sciences ,Nutrition ,Hepatitis ,Digestive Diseases ,Chronic Liver Disease and Cirrhosis ,Liver Disease ,Aetiology ,2.1 Biological and endogenous factors ,Oral and gastrointestinal ,Good Health and Well Being ,Animals ,Gastrointestinal Microbiome ,Humans ,Non-alcoholic Fatty Liver Disease ,Microbiota ,fatty liver ,fibrosis ,obesity ,nutrition ,Medical and Health Sciences ,Biochemistry & Molecular Biology ,Biological sciences ,Biomedical and clinical sciences ,Engineering - Abstract
Impact statementThis invited minireview for the upcoming thematic issue on the microbiome addresses the role of the microbiome in nonalcoholic fatty liver disease (NAFLD). The incidence of NAFLD has increased greatly in recent years in parallel with the rise in obesity and is now believed to have a population prevalence of 20-40%. It is anticipated to soon become the primary cause of liver-related morbidity and mortality, and unfortunately, there are few treatment options. Therefore, there is a critical need for improved understanding of NAFLD pathophysiology to provide new avenues for therapeutic intervention. In this paper, we have reviewed evidence from human and animal model studies that have associated microbiome composition and microbial metabolites with development and progression of NAFLD. We have also discussed proposed mechanisms by which the microbiome could contribute to NAFLD pathogenesis and addressed future directions for this field.
- Published
- 2019
33. Influence of Early Life, Diet, and the Environment on the Microbiome.
- Author
-
Dong, Tien S and Gupta, Arpana
- Subjects
Humans ,Diet ,Environmental Exposure ,Infant ,Infant ,Newborn ,Microbiota ,Gastrointestinal Microbiome ,Host Microbial Interactions ,Early Life Diet ,Environment ,Gut Microbiome ,Irritable Bowel Syndrome ,Obesity ,Stress ,Human Genome ,Prevention ,Nutrition ,Digestive Diseases ,Genetics ,Aetiology ,2.1 Biological and endogenous factors ,Generic health relevance ,Oral and gastrointestinal ,Good Health and Well Being ,Clinical Sciences ,Gastroenterology & Hepatology - Abstract
Advances in sequencing technology and bioinformatics have greatly enhanced our ability to understand the human microbiome. Over the last decade, a growing body of literature has linked nutrition and the environment to the microbiome and is now thought to be an important contributor to overall health. This paper reviews the literature from the past 10 years to highlight the influence of environmental factors such as diet, early life adversity and stress in shaping and modifying our microbiome towards health and disease. The review shows that many factors such as the mode of delivery, breast milk, stress, diet and medications can greatly influence the development of our gut microbiome and potentially make us more prone to certain diseases. By incorporating environmental factors into models that study the microbiome in the setting of health and disease, may provide a better understanding of disease and potentially new areas of treatment. To highlight this, we will additionally explore the role of the environment and the microbiome in the development of obesity and functional bowel disorders.
- Published
- 2019
34. Microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis: The Microbiome, Microbial Markers and Liver Disease Study
- Author
-
Jacobs, Jonathan P, Dong, Tien S, Agopian, Vatche, Lagishetty, Venu, Sundaram, Vinay, Noureddin, Mazen, Ayoub, Walid S, Durazo, Francisco, Benhammou, Jihane, Enayati, Pedram, Elashoff, David, Goodman, Marc T, Pisegna, Joseph, and Hussain, Shehnaz
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Emerging Infectious Diseases ,Chronic Liver Disease and Cirrhosis ,Digestive Diseases ,Prevention ,Clinical Research ,Liver Disease ,Genetics ,Cancer ,Human Genome ,Hepatitis ,Rare Diseases ,Liver Cancer ,Infectious Diseases ,Oral and gastrointestinal ,Good Health and Well Being ,bile acids ,cirrhosis ,microbiome ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
AimCirrhosis is a leading cause of death worldwide, yet there are no well-established risk stratifying tools for lethal complications, including hepatocellular carcinoma (HCC). Patients with liver cirrhosis undergo routine endoscopic surveillance, providing ready access to duodenal aspirate samples that could be a source for identifying novel biomarkers. The aim of this study was to characterize the microbiome and bile acid profiles in duodenal aspirates from patients with liver cirrhosis to assess the feasibility of developing biomarkers for HCC risk stratification.MethodsThirty patients with liver cirrhosis were enrolled in the Microbiome, Microbial Markers, and Liver Disease study between May 2015 and March 2017. Detailed clinical and epidemiological data were collected at baseline and at 6-monthly follow-up visits. Duodenal aspirate fluid was collected at baseline for microbial characterization using 16S ribosomal RNA sequencing and bile acid quantification using mass spectroscopy.ResultsAlcohol-related cirrhosis was associated with reductions in the Bacteroidetes phylum, particularly Prevotella (13-fold reduction), and expansion of Staphylococcus (13-fold increase), compared to hepatitis C virus-related cirrhosis. Participants with hepatic encephalopathy (HE) had less microbial diversity compared to patients without HE (P
- Published
- 2018
35. Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system.
- Author
-
Shera, Simer, Katzka, William, Yang, Julianne C., Chang, Candace, Arias-Jayo, Nerea, Lagishetty, Venu, Balioukova, Anna, Yijun Chen, Dutson, Erik, Zhaoping Li, Mayer, Emeran A., Pisegna, Joseph R., Sanmiguel, Claudia, Pawar, Shrey, Zhang, David, Leitman, Madelaine, Hernandez, Laura, Jacobs, Jonathan P., and Dong, Tien S.
- Subjects
CYTOTOXIC T cells ,KILLER cells ,BARIATRIC surgery ,SLEEVE gastrectomy ,WEIGHT gain ,WEIGHT loss - Abstract
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly 25% of the population and is the leading cause for liver-related mortality. Bariatric surgery is a well-known treatment for MASLD and obesity. Understanding the fundamental mechanisms by which bariatric surgery can alter MASLD can lead to new avenues of therapy and research. Previous studies have identified the microbiome's role in bariatric surgery and in inflammatory immune cell populations. The host innate immune system modulates hepatic inflammation and fibrosis, and thus the progression of MASLD. The precise role of immune cell types in the pathogenesis of MASLD remains an active area of investigation. The aim of this study was to understand the interplay between microbiota composition post-bariatric surgery and the immune system in MASLD. Methods: Eighteen morbidly obese females undergoing sleeve gastrectomy were followed pre-and post-surgery. Stool from four patients, showing resolved MASLD post-surgery with sustained weight loss, was transplanted into antibiotic treated mice. Mice received pre-or post-surgery stool and were fed a standard or high-fat diet. Bodyweight, food intake, and physiological parameters were tracked weekly. Metabolic parameters were measured post-study termination. Results: The human study revealed that bariatric surgery led to significant weight loss (p > 0.05), decreased inflammatory markers, and improved glucose levels six months post-surgery. Patients with weight loss of 20% or more showed distinct changes in blood metabolites and gut microbiome composition, notably an increase in Bacteroides. The mouse model confirmed surgery-induced microbiome changes to be a major factor in the reduction of markers and attenuation of MASLD progression. Mice receiving post-surgery fecal transplants had significantly less weight gain and liver steatosis compared to pre-surgery recipients. There was also a significant decrease in inflammatory cytokines interferon gamma, interleukin 2, interleukin 15, and mig. This was accompanied by alterations in liver immunophenotype, including an increase in natural killer T cells and reduction of Kupfer cells in the post-surgery transplant group. Discussion: Our findings suggest surgery induced microbial changes significantly reduce inflammatory markers and fatty liver progression. The results indicate a potential causal link between the microbiome and the host immune system, possibly mediated through modulation of liver NKT and Kupffer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis
- Author
-
Aby, Elizabeth S., Pham, Nguyen V., Yum, Jung J., Dong, Tien S., Ghasham, Hussein, Bedier, Fatima, Malley, Claire, Schaenman, Joanna, and Saab, Sammy
- Published
- 2021
- Full Text
- View/download PDF
37. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1c
- Author
-
Dong, Tien S, Aby, Elizabeth S, Benhammou, Jihane N, Kawamoto, Jenna, Han, Steven-Huy, May, Folasade P, and Pisegna, Joseph R
- Subjects
Hepatitis ,Infectious Diseases ,Chronic Liver Disease and Cirrhosis ,Clinical Research ,Digestive Diseases ,Nutrition ,Liver Disease ,Emerging Infectious Diseases ,Obesity ,Hepatitis - C ,Diabetes ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Metabolic and endocrine ,Good Health and Well Being ,Hepatitis C virus ,Hemoglobin A1c ,Diabetes mellitus ,Direct-acting antivirals ,Metabolic syndrome - Abstract
AimTo determine whether successful treatment with directacting antivirals (DAA) is associated with improvements in hemoglobin A1c (HbA1c) and if type 2 diabetes mellitus (T2DM) or metabolic syndrome affects sustained virologic response (SVR).MethodsWe performed a retrospective analysis of all hepatitis C virus (HCV) patients at the VA Greater Los Angeles Healthcare System treated with varying DAA therapy between 2014-2016. Separate multivariable logistic regression was performed to determine predictors of HbA1c decrease ≥ 0.5 after DAA treatment and predictors of SVR 12-wk post treatment (SVR12).ResultsA total of 1068 patients were treated with DAA therapy between 2014-2016. The presence of T2DM or metabolic syndrome did not adversely affect SVR12. 106 patients had both HCV and T2DM. Within that cohort, patients who achieved SVR12 had lower mean HbA1c pre treatment (7.35 vs 8.60, P = 0.02), and lower mean HbA1c post-treatment compared to non-responders (6.55 vs 8.61, P = 0.01). The mean reduction in HbA1c after treatment was greater for those who achieved SVR12 than for non-responders (0.79 vs 0.01, P = 0.03). In adjusted models, patients that achieved SVR12 were more likely to have a HbA1c decrease of ≥ 0.5 than those that did not achieve SVR12 (adjusted OR = 7.24, 95%CI: 1.22-42.94).ConclusionIn HCV patients with T2DM, successful treatment with DAA was associated with a significant reduction in HbA1c suggesting that DAA may have a role in improving insulin sensitivity. Furthermore, the presence of T2DM or metabolic syndrome does not adversely affect SVR12 rates in patients treated with DAA.
- Published
- 2018
38. Race affects SVR12 in a large and ethnically diverse hepatitis C-infected patient population following treatment with direct-acting antivirals: Analysis of a single-center Department of Veterans Affairs cohort.
- Author
-
Benhammou, Jihane N, Dong, Tien S, May, Folasade P, Kawamoto, Jenna, Dixit, Ram, Jackson, Samuel, Dixit, Vivek, Bhattacharya, Debika, Han, Steven B, and Pisegna, Joseph R
- Subjects
Humans ,Hepacivirus ,Hepatitis C ,Antiviral Agents ,Treatment Outcome ,Multivariate Analysis ,Logistic Models ,Retrospective Studies ,Cohort Studies ,Middle Aged ,African Continental Ancestry Group ,European Continental Ancestry Group ,Adherence ,Veterans Affairs ,direct drug acting ,direct‐acting antivirals ,drug metabolism ,ethnicity ,medication procession ratio ,polymorphisms ,race ,racial disparity ,sustained virological response 12 ,direct-acting antivirals ,Medicinal and Biomolecular Chemistry ,Pharmacology and Pharmaceutical Sciences - Abstract
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease. HCV cure has been linked to improved patient outcomes. In the era of direct-acting antivirals (DAAs), HCV cure has become the goal, as defined by sustained virological response 12 weeks (SVR12) after completion of therapy. Historically, African-Americans have had lower SVR12 rates compared to White people in the interferon era, which had been attributed to the high prevalence of non-CC interleukin 28B (IL28B) type. Less is known about the association between race/ethnicity and SVR12 in DAA-treated era. The aim of the study is to evaluate the predictors of SVR12 in a diverse, single-center Veterans Affairs population. We conducted a retrospective study of patients undergoing HCV therapy with DAAs from 2014 to 2016 at the VA Greater Los Angeles Healthcare System. We performed a multivariable logistic regression analysis to determine predictors of SVR12, adjusting for age, HCV genotype, DAA regimen and duration, human immunodeficiency virus (HIV) status, fibrosis, nonalcoholic fatty liver disease (NAFLD) fibrosis score, homelessness, mental health, and adherence. Our cohort included 1068 patients, out of which 401 (37.5%) were White people and 400 (37.5%) were African-American. Genotype 1 was the most common genotype (83.9%, N = 896). In the adjusted models, race/ethnicity and the presence of fibrosis were statistically significant predictors of non-SVR. African-Americans had 57% lower odds for reaching SVR12 (adj.OR = 0.43, 95% CI = 1.5-4.1) compared to White people. Advanced fibrosis (adj.OR = 0.40, 95% CI = 0.26-0.68) was also a significant predictor of non-SVR. In a single-center VA population on DAAs, African-Americans were less likely than White people to reach SVR12 when adjusting for covariates.
- Published
- 2018
39. Impact of sustained virologic response on chronic kidney disease progression in hepatitis C
- Author
-
Aby, Elizabeth S, Dong, Tien S, Kawamoto, Jenna, Pisegna, Joseph R, and Benhammou, Jihane N
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Kidney Disease ,Clinical Research ,Hepatitis ,Substance Misuse ,Prevention ,Digestive Diseases ,Hepatitis - C ,Emerging Infectious Diseases ,Infectious Diseases ,Chronic Liver Disease and Cirrhosis ,Liver Disease ,Detection ,screening and diagnosis ,4.1 Discovery and preclinical testing of markers and technologies ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Renal and urogenital ,Infection ,Good Health and Well Being ,Hepatitis C ,Direct-acting antivirals ,Chronic kidney disease ,End stage renal disease ,Sustained virological response ,Clinical sciences - Abstract
AIM:To determine how sustained virological response at 12 wk (SVR12) with direct acting antivirals (DAAs) for the treatment of hepatitis C virus (HCV) infection affects chronic kidney disease (CKD) progression. METHODS:A retrospective analysis was performed in patients aged ≥ 18 years treated for HCV with DAAs at the VA Greater Los Angeles Healthcare System from 2014-2016. The treatment group was compared to patients with HCV from 2011-2013 who did not undergo HCV treatment, prior to the introduction of DAAs; the control group was matched to the study group in terms of age, gender, and ethnicity. Analysis of variance and co-variance was performed to compare means between SVR12 subgroups adjusting for co-variates. RESULTS:Five hundred and twenty-three patients were evaluated. When comparing the rate of change in estimated glomerular filtration rate (eGFR) one-year after HCV treatment to one-year before treatment, patients who achieved SVR12 had a decline in GFR of 3.1 mL/min ± 0.75 mL/min per 1.73 m2 compared to a decline in eGFR of 11.0 mL/min ± 2.81 mL/min per 1.73 m2 in patients who did not achieve SVR12 (P = 0.002). There were no significant clinical differences between patients who achieved SVR12 compared to those who did not in terms of cirrhosis, treatment course, treatment experience, CKD stage prior to treatment, diuretic use or other co-morbidities. The decline in eGFR in those with untreated HCV over 2 years was 2.8 mL/min ± 1.0 mL/min per 1.73 m2, which was not significantly different from the eGFR decline noted in HCV-treated patients who achieved SVR12 (P = 0.43). CONCLUSION:Patients who achieve SVR12 have a lesser decline in renal function, but viral eradication in itself may not be associated improvement in renal disease progression.
- Published
- 2017
40. Enhanced CTLA‐4 blockade anti‐tumor immunity with APG‐157 combination in a murine head and neck cancer.
- Author
-
Shin, Daniel Sanghoon, Basak, Saroj, Veena, Mysore S., Comin‐Anduix, Begoña, Bhattacharya, Arjun, Dong, Tien S., Ko, Albert, Han, Philip, Jacobs, Jonathan, Moatamed, Neda A., Avila, Luis, Pellegrini, Matteo, Wang, Marilene, and Srivatsan, Eri S.
- Subjects
HEAD & neck cancer ,IMMUNE checkpoint inhibitors ,CYTOTOXIC T lymphocyte-associated molecule-4 ,MEDICAL botany ,FECAL analysis ,TUMOR microenvironment - Abstract
Background: A phase I clinical study for patients with locally advanced H&N cancer with a new class of botanical drug APG‐157 provided hints of potential synergy with immunotherapy. We sought to evaluate the efficacy of the combination of APG‐157 and immune checkpoint inhibitors. Methods: CCL23, UM‐SCC1 (human), and SCCVII (HPV−), MEER (HPV+) (murine) H&N cancer cell lines were utilized for in vitro and in vivo studies. We measured tumor growth by treating the mice with APG‐157, anti‐PD‐1, and anti‐CTLA‐4 antibody combinations (8 groups). The tumor microenvironments were assessed by multi‐color flow cytometry, immunohistochemistry, and RNA‐seq analysis. Fecal microbiome was analyzed by 16S rRNA sequence. Results: Among the eight treatment groups, APG‐157 + anti‐CTLA‐4 demonstrated the best tumor growth suppression (p = 0.0065 compared to the control), followed by anti‐PD‐1 + anti‐CTLA‐4 treatment group (p = 0.48 compared to the control). Immunophenotype showed over 30% of CD8+ T cells in APG‐157 + anti‐CTLA‐4 group compared to 4%–5% of CD8+ T cells for the control group. Differential gene expression analysis revealed that APG‐157 + anti‐CTLA‐4 group showed an enriched set of genes for inflammatory response and apoptotic signaling pathways. The fecal microbiome analysis showed a substantial difference of lactobacillus genus among groups, highest for APG‐157 + anti‐CTLA‐4 treatment group. We were unable to perform correlative studies for MEER model as there was tumor growth suppression with all treatment conditions, except for the untreated control group. Conclusions: The results indicate that APG‐157 and immune checkpoint inhibitor combination treatment could potentially lead to improved tumor control. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients
- Author
-
Weir, Ronald E., Lyttle, Christopher S., Meltzer, David O., Dong, Tien S., and Ruhnke, Gregory W.
- Published
- 2018
42. Intraperitoneal Treatment of Kisspeptin Suppresses Appetite and Energy Expenditure and Alters Gastrointestinal Hormones in Mice
- Author
-
Dong, Tien S., Vu, John P., Oh, Suwan, Sanford, Daniel, Pisegna, Joseph R., and Germano, Patrizia
- Published
- 2020
- Full Text
- View/download PDF
43. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices
- Author
-
Dong, Tien S., Kalani, Amir, Aby, Elizabeth S., Le, Long, Luu, Kayti, Hauer, Meg, Kamath, Rahul, Lindor, Keith D., and Tabibian, James H.
- Published
- 2019
- Full Text
- View/download PDF
44. Patient Satisfaction and Healthcare Utilization Using Telemedicine in Liver Transplant Recipients
- Author
-
Le, Long B., Rahal, Harman K., Viramontes, Matthew R., Meneses, Katherine G., Dong, Tien S., and Saab, Sammy
- Published
- 2019
- Full Text
- View/download PDF
45. 24 DISCRIMINATION EXPOSURE IMPACTS UNHEALTHY PROCESSING OF FOOD-CUES: CROSSTALK BETWEEN THE BRAIN AND GUT
- Author
-
Zhang, Xiaobei, primary, Wang, Hao, additional, Kilpatrick, Lisa A., additional, Dong, Tien S., additional, Gee, Gilbert C., additional, Beltrán-Sánchez, Hiram, additional, Wang, May, additional, Vaughan, Allison, additional, and Gupta, Arpana, additional
- Published
- 2023
- Full Text
- View/download PDF
46. Additional file 1 of Multi-omics profiles of the intestinal microbiome in irritable bowel syndrome and its bowel habit subtypes
- Author
-
Jacobs, Jonathan P., Lagishetty, Venu, Hauer, Megan C., Labus, Jennifer S., Dong, Tien S., Toma, Ryan, Vuyisich, Momchilo, Naliboff, Bruce D., Lackner, Jeffrey M., Gupta, Arpana, Tillisch, Kirsten, and Mayer, Emeran A.
- Abstract
Additional file 1: Figure S1. Significant associations were seen across all pairwise combinations of datasets. (A) Procrustes analysis was used to superimpose dbRDA ordinations of the indicated pairs of datasets. IBS and HC samples are denoted by color. (B) Mantel test of association for all pairwise combinations of datasets. All were significant, with color indicating level of significance. Figure S2. Metabolites that were differentially abundant in IBS vs. HC or IBS-D vs. IBS-C and were associated with the gut microbiome by metabolic modeling. (A) Metabolites that were associated with the community metabolic potential (CMP) scores derived from predicted bacterial gene content are shown. Metabolomics and predicted metagenomics data were available for 361 subjects. Each sample is plotted by its CMP score and the log2 of the normalized metabolite level. The dashed lines represent linear regression of metabolite levels with CMP scores and the number in the upper right of each plot indicates the R2. (B) Metabolites that were associated with CMP scores derived from the metatranscriptome. Metabolomics and metatranscriptomics data were available for 234 subjects. Figure S3. IBS-D is differentiated from IBS-C by diverse functional shifts including increased polyamines, bile acids, glutamate synthesis, and ethanolamine utilization. (A) Differentially abundant taxa (q
- Published
- 2023
- Full Text
- View/download PDF
47. Improved Psychosocial Measures Associated with Physical Activity May Be Explained by Alterations in Brain-Gut Microbiome Signatures
- Author
-
Guan, Michelle, primary, Dong, Tien S., additional, Subramanyam, Vishvak, additional, Guo, Yiming, additional, Bhatt, Ravi, additional, Vaughan, Allison, additional, Barry, Robert L., additional, and Gupta, Arpana, additional
- Published
- 2022
- Full Text
- View/download PDF
48. How Discrimination Gets Under the Skin: Biological Determinants of Discrimination Associated with Dysregulation of the Brain-Gut Microbiome System and Psychological Symptoms
- Author
-
Dong, Tien S., primary, Gee, Gilbert C., additional, Beltran-Sanchez, Hiram, additional, Wang, May, additional, Osadchiy, Vadim, additional, Kilpatrick, Lisa A., additional, Chen, Zixi, additional, Subramanyam, Vishvak, additional, Zhang, Yurui, additional, Guo, Yinming, additional, Labus, Jennifer S., additional, Naliboff, Bruce, additional, Cole, Steve, additional, Zhang, Xiaobei, additional, Mayer, Emeran A., additional, and Gupta, Arpana, additional
- Published
- 2022
- Full Text
- View/download PDF
49. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome
- Author
-
Choo, Charlene, primary, Mahurkar-Joshi, Swapna, additional, Dong, Tien S., additional, Lenhart, Adrienne, additional, Lagishetty, Venu, additional, Jacobs, Jonathan P., additional, Labus, Jennifer S., additional, Jaffe, Nancee, additional, Mayer, Emeran A., additional, and Chang, Lin, additional
- Published
- 2022
- Full Text
- View/download PDF
50. Leveraging the Microbiome for Obesity: Moving From Form to Function
- Author
-
Lee, Anna H., primary, Manly, Amanda, additional, and Dong, Tien S., additional
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.